Drug profile · INN
porfimer sodium
PHOTOBARR
porfimer sodium (PHOTOBARR) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
FDA: approved EMA: withdrawn Antineoplastic and immunomodulating agents (L01) L01XD01
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — porfimer sodium
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
porfimer sodium (PHOTOBARR) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN porfimer sodium
Brand PHOTOBARR
Mechanism DNA inhibitor
Target DNA
Therapeutic class Antineoplastic and immunomodulating agents (L01)
Route INJECTION
Formulation INJECTABLE
ATC code L01XD01
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is porfimer sodium?
porfimer sodium (PHOTOBARR) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for porfimer sodium?
PHOTOBARR is a marketed brand name for porfimer sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of porfimer sodium?
porfimer sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.